About
Deliverance has established core proprietary technologies that provide solutions for the immediate management and control of bleeding, hemorrhage, and shock due to blood vessel perforations that can occur during minimally invasive surgeries, open and vascular surgeries, andas a result of trauma. The companys Lap Braided S&F Catheter isdesigned for use in emergency situations caused by severe bleeding during minimally invasive surgeries. The device has a thin profile and flexible distal portion that permits rapid sealing of perforations of various sizes and at different locations inthe major blood vessel system of the abdomen and thorax. The Open Surgery and Field S&F Catheter uses proprietary technology that allows complete and rapid sealing of perforations with a dual blockade. Specially designed sealing cushions discretely block the perforation from inside and outside the vessel wall. The device also provides an option to keep an open line to the injured vessel, allowing liquid transfusion with flow rates greater than 500 milliliters per minute to efficiently treat possible hypovolemia.
Funding history · 1 round · $1.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Deliverance's primary focus?
- Deliverance focuses on developing proprietary technologies for the immediate management and control of bleeding, hemorrhage, and shock during surgeries and trauma.
- When was Deliverance founded?
- Deliverance was founded in March 2009.
- What is the current status of Deliverance?
- Deliverance is currently inactive, as of December 2017.
- What is the purpose of Deliverance's Lap Braided S&F Catheter?
- The Lap Braided S&F Catheter is designed for emergency situations involving severe bleeding during minimally invasive surgeries, allowing rapid sealing of perforations in major blood vessels.
- How does Deliverance's Open Surgery and Field S&F Catheter work?
- The Open Surgery and Field S&F Catheter uses proprietary technology for complete and rapid sealing of perforations with a dual blockade, blocking from both inside and outside the vessel wall. It also allows for liquid transfusion.
- How much funding has Deliverance raised in total?
- Deliverance has raised a total of $1,000,000 in Seed funding. For a full financing history, users can refer to startupim.
- What is Deliverance's employee count?
- Deliverance has between 11-50 employees, with an exact count of 31 employees.
- Who are the founders of Deliverance?
- The founders of Deliverance are Ehud Almon and Dan Aravot.
- What are the primary target markets for Deliverance's products?
- Deliverance targets the Defense, Safety & Security, National Security, Military, Healthcare & Life Sciences, Medical Devices Industry, Medical Products, Healthcare, and Providers markets.